Current Concepts in Pain Management

Slides:



Advertisements
Similar presentations
Cindy Powers Magrini, PharmD, BCPS
Advertisements

The purpose is not to imply everyone on controlled substances will become addicted!!! Everyone on controlled substances is, however, at increased risk.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007.
Introduction to Pain/Opioid Management
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
Slide 1 of 12 From JS Merlin, MD, at Chicago, IL: May 20, 2013, IAS-USA. IAS–USA Jessica S. Merlin, MD, MBA Assistant Professor of Medicine University.
Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.
1 December 8, 2015 Crista M. Taylor, LCSW-C Director, Information, Planning and Development Adrienne Breidenstine, MSW Director of Opioid Overdose Prevention.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Pain Management: Narcotics, Implantable Therapies Maher Fattouh MD Adjunct Assistant Clinical Professor University Wisconsin Medical Director, Advanced.
CDC Guideline for Prescribing Opioids for Chronic Pain Presenter’s Name Presenter’s Title Title of Event Date of Event Centers for Disease Control and.
An unpleasant sensory or emotional experience associated with actual or potential tissue damage The World Health Organization (WHO) has stated that pain.
Implementing a Urine Drug Screening Protocol to Teach Appropriate Opioid Prescribing in a Residency Practice STFM Annual Conference May 2, 2016 Nata Young,
Opioids Tapering Melissa B. Weimer, DO, MCR. Disclosures Dr. Weimer is a consultant for INFORMed, IMPACT education, and the American Association of Addiction.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
Prepared by Dr. Ramin Safakish, MD, FRCPC – March 2016.
TRAUMA AND OPIOIDS SUMMIT OUTPATIENT OPIOID THERAPY: MITIGATING RISKS Perry G. Fine, MD Professor of Anesthesiology Department of Anesthesiology School.
CDC Guideline for Prescribing Opioids for Chronic Pain- United States-2016 Gisele J. Girault, M.D. First Choice Healthcare Columbia, SC.
Alice Messer, FNP-BC, DNP(c)
The Truth about Opioids: Treating Pain in the United States
OPIOID EPIDEMIC.
Wireless Access SSID: cwag2017
Navigating the Opioid Dilemma:
*Risk Evaluation and Mitigation Strategy
Oh The Lies That We Have been Told Weaning Opioid Therapy: How and Why
Cover slide.
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
Opioids Aware A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain.
How is your comfort level in regards to managing patients with CNCP on opioids now? Not comf at all Very.
Joann Yoon Kang, JD Policy and Partnerships Team Lead
THE OPIOID CRISIS Mississippi Board of Nursing
Medication-Assisted Therapy at Coleman Profession Services
MWCC.MS.GOV  Services  Medical Fee Schedule
Alcohol, Other Drugs, and Health: Current Evidence
Case Presentations.
Understanding the Opioid Epidemic
Opioids in chronic pain
STOP! Safe Treatment of Pain
Opioids – A Pharmaceutical Perspective on Prescription Drugs
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Deputy Health Officer Allegany and Garrett Counties
Risk evaluation and mitigation for use of opioids in chronic pain
ROOM project Addressing the Opioid Epidemic in the U.P.
Opioid Prescribing & Monitoring
Prescribing Opioids in Vermont
Key Performance Indicators
Differentiating Drug-Seeking Behavior From Poorly Controlled Pain
Barbara Allison-Bryan, MD
2017 Opioid Prescriber Survey Preliminary Results
Opioid Review and MAT Clinic
Opiate Roundtable March 29, 2018 Karen Burgess, MD
Opioids in Butte County
Prescription Drug Monitoring Program
RESPONSIBLE OPIOID PRESCRIBING cdc guidelines and updates
2019 Medicare Part D Rule Opioid-related Provisions
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
Prescription Drug Monitoring Program
Essentials of Good Pain Care: A Team-Based Approach
Opioid prescribing workflow in the electronic medical record.
Guideline for the Treatment of Alcohol Use Disorder in the Outpatient Setting with Intramuscular Naltrexone Assess Candidacy for IM Naltrexone Meets DMS-V.
Championing Evidence-Based Care in Patients With Acute Low Back Pain
SUBROGATION AND THE OPIOID EPIDEMIC
Substance Use Prevention for Young Adults and Higher Education
Strategic Initiatives to Address Opioid Overdose & Addiction
The Silent Killer in America
Tapering and Discontinuing Chronic Opioid Therapy
Pain Management JEFFREY TAN HO, D.O.
PMP Advisory Committee
Presentation transcript:

Current Concepts in Pain Management How physical therapy can help CDC Guidelines for Chronic Pain Management Melanie Mailand, PT, DPT Lori Poss, APNP

Objectives Overview of prescription rates, economic cost, statistics Review of 12 CDC recommendations for chronic pain management Discuss April Wisconsin mandate

Pain 5th Vital sign

An estimated 20% of patients presenting to providers offices for noncancerous issues, leave with or receive an opioid prescription. In 2012, Health Care Providers (HCP) wrote 259 million prescriptions for opioid pain management. One American dies every 19 minutes from opioid or heroin overdose. The economic impact of drug and alcohol misuse and addiction amounts to $442 billion each year. In 2016, opioid drug overdoses doubled.

Chronic pain is defined as pain which lasts > 3 months or past the time of normal tissue healing. These guidelines are recommendations for the outpatient setting OUTSIDE of active cancer treatment, palliative care and end of life care.

Guideline #1 Nonpharmacological therapy and nonopioid pharmacology therapy are preferred for chronic pain. NSAIDS Joint injections Selective antidepressants Selective anticonvulsants PT Pain school Mental Health Referral Aquatic exercising Weight loss CBT

Guideline #2 Before starting opioid therapy for chronic pain, clinicians should establish treatment goals with all patients, including realistic goals for pain and function and should consider how opioid therapy will be discontinued if benefits do not outweigh the risks. Clinicians should continue opioid therapy only if there is clinically meaningful improvement in pain and function that outweighs risks to patient safety.

Pain Scale

Guideline#3 Before starting and periodically during opioid therapy, clinicians should discuss with patients known risks and realistic benefits of opioid therapy and patient and clinicians responsibilities for managing therapy. There is no good evidence that opioids improve pain or function with long term use. Complete pain relief is unlikely.

Guideline#4 When starting opioid therapy, clinicians should prescribe immediate release instead of long acting opioids. This is change since 2014. Prior to that, ER/LA was recommended.

Guideline #5 When opioids are started, clinicians should prescribe the lowest effective dose. Clinicians should use caution when prescribing at ANYdose but patients should not be started on any dose higher than 50 morphine milligram equivalent (MME)/day. The CDC strongly discourages daily doses greater than or equal to 90 MME/day.

Guideline #6 Long term opioid use often begins with treatment for acute care. Use lowest effective dose Shortest amount of time **** 3-7 days for acute injury

Guideline #7 Clinicians should evaluate benefits and harms with patients within 1-4 weeks of starting opioid therapy for chronic pain or if dose escalation. Contextual evidence review found that patients who did not have pain relief at 1 month are unlikely to have pain relief at 6 months.

Guideline #8 Before starting and periodically during continuation of opioid therapy, clinicians should evaluate risk factors for opioid related harms and incorporate strategies to mitigate risk. Previous hx of drug misuse Pregnancy Renal or hepatic insufficiency Age > 65 Associated Mental Health conditions

Guideline #9 Clinicians should review the patient’s history of controlled substance prescriptions using state prescription drug monitoring (PMDP) data to determine whether the patient is receiving other opioids or dangerous combinations that put him or her at risk for overdose. Clinicians should review PMDP when initiating opioid therapy and periodically as well.

Guideline #10 When prescribing opioids for chronic pain, clinicians should use urine drug testing before starting opioid therapy and consider urine drug testing at least annually to assess for prescribed medications as well as other controlled prescription drugs or illicit drugs.

Guideline #11 Clinicians should avoid prescribing opioid pain medication and benzodiazepines together. Concurrent use can triple the risk of overdose.

Guideline #12 Clinicians should offer or arrange medication assisted treatment of buprenorphine or methadone in combination with behavioral therapies in patients with opioid use disorder. Methadone clinics - clinicians must be trained to use/prescribe methadone.

April 2017 Wisconsin state law will require prescribers to review the PDMP before prescribing ANY controlled substance for greater than a 3 day supply. dsps@Wisconsin.gov